Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Apicomplexa & Kinetoplastidae

ABSTRACT: Bacterial, apicomplexan and kinetoplastid vector-borne diseases from tropical canines in Bangkok, Thailand

PROVIDER: PRJNA528154 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10895100_1.fastq.gz	Fastqsanger.gz
	SRR10895100_2.fastq.gz	Fastqsanger.gz
	SRR10895101_1.fastq.gz	Fastqsanger.gz
	SRR10895101_2.fastq.gz	Fastqsanger.gz
	SRR10895102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 794

Similar Datasets

Apicomplexa

Project description:Transcriptomes of apicomplexan parasites

| PRJNA557242 | ENA

Apicomplexa

Project description:Characterization of apicomplexan polyadenylation sites

| PRJNA436572 | ENA

freshwater metagenome

Project description:Metagenomic analysis in Bangkok, Thailand

| PRJDB6958 | ENA

Investigation into Vector-Borne diseases in people in Australia

Project description:Investigation into Vector-Borne diseases in people in Australia

| PRJEB61730 | ENA

Project description:Enterovirus infections in kindergartens, Bangkok, Thailand

| PRJNA974406 | ENA

human metagenome

Project description:Metegenomic sequencing of blood from patients with vector-borne diseases

| PRJNA518922 | ENA

Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand, 2018

Project description:Genomic surveillance of N. gonorrhoeae in Bangkok, Thailand

| PRJEB47915 | ENA

Infection with Burkholderia pseudomallei – immune correlates of survival in acute melioidosis

Project description:Melioidosis is a neglected tropical disease caused by the Gram-negative bacterium Burkholderia pseudomallei. It is widespread in Southeast Asia and under-reported across tropical regions worldwide. Patients present with a range of clinical syndromes including sepsis, pneumonia and focal abscesses, with a mortality rate of 40% in hospitalized patients in Thailand. Up to two-thirds of patients with melioidosis have diabetes mellitus. In this experiment we sought to characterize pathways activated by whole killed B. pseudomallei bacteria and by three vaccine candidate proteins from B. pseudomallei, BPSL2520 (uncharacterized protein), BPSS1525 (BopE) and BPSL2096 (AhpC) in patients with diabetes and acute melioidosis.

2017-09-22 | E-MTAB-6093 | biostudies-arrayexpress

Project description:Mosquito vector-associated microbiota: metabarcoding bacteria and eukaryotic symbionts across habitat types in Thailand endemic for dengue and other arthropod-borne diseases

| PRJNA406988 | ENA

A Phase 2 Randomized Sequence Open Label Expanded Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

Project description:Human immunodeficiency virus (HIV) disproportionately affects men who have sex with men (MSM) and transgender women (TGW). Safe and acceptable topical HIV prevention methods that target the rectum are needed. MTN-017 was a phase 2, 3-period, randomized sequence, open-label, expanded safety and acceptability crossover study comparing rectally applied reduced-glycerin (RG) 1% tenofovir (TFV) and oral emtricitabine/TFV disoproxil fumarate (FTC/TDF). In each 8-week study period participants were randomized to RG-TFV rectal gel daily, or RG-TFV rectal gel before and after receptive anal intercourse (RAI; or at least twice weekly in the event of no RAI), or daily oral FTC/TDF. MSM and TGW (n = 195) were enrolled from 8 sites in the United States, Thailand, Peru, and South Africa with mean age of 31.1 years (range 18-64). The clinical results were reported here https://www.ncbi.nlm.nih.gov/pubmed/27986684. For the gene expression study, rectal biopsies were obtained from a subset of participants (n = 36) in the United States (Pittsburgh) and Thailand (Bangkok). Biopsies were provided at baseline and after each study period.

2020-07-07 | GSE138723 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data